- MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknownsChrysoula Dosiou
Division of EndocrinologyStanford University School of Medicine, Stanford, California, USA
Eur J Endocrinol 176:R21-R38. 2017..Finally, we delineate the remaining uncertainties in this field and emphasize the need for a sufficiently powered, placebo-controlled RCT on the treatment of IMH early in the first trimester of pregnancy...
- Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant womenChrysoula Dosiou
Division of Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, S025, Stanford, California 94305, USA
J Clin Endocrinol Metab 97:1536-46. 2012..Hypothyroidism in pregnancy can lead to adverse maternal and fetal outcomes. Although screening of high-risk women is advocated, universal screening remains controversial...
- Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysisChrysoula Dosiou
Division of Endocrinology, Department of Medicine, Stanford University Medical Center, 300 Pasteur Drive, S025, Stanford, California 94305, USA
Eur J Endocrinol 158:841-51. 2008..Our objective was to examine the cost-effectiveness of screening pregnant women for autoimmune thyroid disease...